1. Introduction {#sec1}
===============

Early life perturbations such as stress, inflammation, or infection produce long-term effects on the developing brain, increasing subsequent risk of neuropsychiatric disorders throughout life. Despite advances in understanding the mechanistic roles of the maternal milieu in normal and pathological neurodevelopment, significant progress in biomarker discovery and the treatment of neuropsychiatric disorders has not been made. This is in part due to the multifactorial presentation of neuropsychiatric conditions and common comorbidities, including chronic gastrointestinal (GI) dysfunction. As a growing body of evidence suggests that a critical window for neurodevelopment overlaps with microbial colonization of the gastrointestinal tract, it is likely that environmental perturbations could similarly impact both systems ([@bib14], [@bib101]).

In particular, maternal stress during pregnancy has been associated with an increased incidence of neurodevelopmental disorders and gastrointestinal dysfunction ([@bib22], [@bib70], [@bib79]). Among the many maladaptive effects it exhibits on the mother, chronic stress during pregnancy alters vaginal host immunity and resident bacteria composition ([@bib31], [@bib116], [@bib121]). The vaginal ecosystem is a dynamic community shown to be sensitive to a variety of factors such as body composition, diet, infection, antibiotic treatment and stress ([@bib9], [@bib21], [@bib114], [@bib87], [@bib56]), and is poised to communicate information about the state of the pending external environment. Maternal vaginal microflora is ingested into the neonatal gut during parturition, establishing the initial microbial population. Therefore, perturbations to the vaginal ecosystem could have significant consequences for offspring development and disease risk. For example, dysbiosis of vaginal microflora can impact the microbial assembly of the neonatal gut where decreased diversity and stability of microbial populations could promote disruption of key processes involved in host metabolism, immune function, and neurodevelopment ([@bib92], [@bib77], [@bib67], [@bib30]). The hypothalamic-pituitary-adrenal (HPA) stress axis may be particularly sensitive to gut microbial disruption as its development overlaps with the initial colonization of the neonatal gut ([@bib14], [@bib117]). Critically, HPA axis dysregulation has long been recognized as a hallmark of inflammatory and psychiatric disorders, where both hyper- and hypo-responsivity have been reported ([@bib7], [@bib49], [@bib74], [@bib60]).

In this review, we discuss the influence of maternal-infant microbial transmission on early life programming, and the ability for stress to alter this process ([Fig. 1](#fig1){ref-type="fig"}). Specifically, we will highlight a potential mechanistic role for the neonate gut microbiome to contribute to nutrient metabolism, thereby linking itself to the developing brain. We outline the bidirectional communication between the HPA stress axis and gut microbiota, and consider the implication of early microbial dysbiosis during critical neurodevelopmental windows, emphasizing potential sex-specific consequences across a number of behavioral domains. We conclude by providing some perspectives on future directions in this area.

2. The vaginal microbiome {#sec2}
=========================

The female reproductive tract and its microflora form a dynamic ecosystem, with the vaginal mucosal environment determining the survival of specific bacterial species, and the microflora in turn contributing to the vaginal environment. The hormonal control of vaginal glycogen content is believed to be a major factor shaping the microbial composition and stability within the female reproductive tract. Upon estradiol stimulation, glycogen is deposited onto mature vaginal epithelium where it is metabolized to glucose by the epithelial cells and bacterial enzymes ([@bib59], [@bib88]). *Lactobacillus* was the first bacterial genus identified with the capacity to metabolize vaginal glucose into lactic acid and hydrogen peroxide, and it is predominantly these H~2~O~2~-producing strains that thrive in low vaginal pH conditions. By maintaining low vaginal pH and producing H~2~O~2~, as well as by stimulating the immune system and preventing further colonization through competitive exclusion, healthy *Lactobacillus* populations protect the female reproductive tract from infection by opportunistic pathogens. Indeed, overgrowth of *Gardnerella vaginalis*, a harmful toxin-producing bacterium, has been associated with increased vaginal pH and loss of H~2~O~2~-producing *Lactobacillus* ([@bib47], [@bib71], [@bib99], [@bib111], [@bib115]).

During pregnancy, steroid hormones such as progesterone and estradiol stimulate high levels of glycogen deposition onto vaginal epithelium further promoting the growth of favorable acidophilic vaginal bacteria like *Lactobacillus*. However, these hormones also play a significant role in immunosuppression during pregnancy. While this effect is adaptive as it allows tolerance of the developing offspring, it may also increase maternal vulnerability to environmental challenges ([@bib113], [@bib125]). Stress during pregnancy can exaggerate the normal physiological immunosuppression, thereby increasing maternal vulnerability to genitourinary infection and its related obstetrical risks including associations with neurodevelopmental disorders. For instance, in a recent epidemiological study, mothers of children with autism spectrum disorder reported greater frequency and severity of vaginal bacterial infections during pregnancy ([@bib124]). Importantly, recurrent vaginal bacterial and fungal infections can trigger a variety of local and global responses that may result in the eventual loss of the beneficial *Lactobacillus-*dominant vaginal ecosystem ([@bib46], [@bib38]). The downstream effects of stress-related *Lactobacillus* depletion on maternal-infant microbial transmission, host metabolism, and immune function remain to be examined, but likely include important consequences for the developing brain.

3. Maternal-infant microbial transmission {#sec3}
=========================================

Two different modes of maternal-infant transmission have been proposed: 1) horizontal, where the infant\'s predominant microbial acquisition is from the external environment, and 2) vertical, where there is maternal transmission of vaginal microbes during parturition ([@bib15]). Emerging evidence, however, suggests that vertical transmission primarily accounts for the initial colonization of the infant gut, which can influence maturation of the gastrointestinal tract and ensure the proper extraction of energy and macromolecules essential for normal development ([@bib15], [@bib23], [@bib25], [@bib63]). Recent appreciation for the influence of this mother-infant microbial transmission on offspring development has sparked new interest in understanding the potential connection between perturbations during pregnancy and early life programming.

3.1. Vertical transmission during parturition {#sec3.1}
---------------------------------------------

At the turn of the twentieth century, French pediatrician Henry Tissier proposed that human infants develop within a sterile environment, with primary microbial exposure occurring through contact of the newborn with maternal vaginal microbiota ([@bib110]). However, recent studies have cast some reservations on the 'sterile' womb hypothesis ([@bib42]). Maternal gut bacteria have been isolated in umbilical cord blood, amniotic fluid, meconium, and placental and fetal membranes of infants from uncomplicated and otherwise healthy pregnancies ([@bib53], [@bib86], [@bib100], [@bib45], [@bib1]). However, the mechanism by which the maternal gut bacteria gain access to the developing fetus is not well understood and needs to be further characterized. Nevertheless, during vaginal delivery, the amniotic fluid is exposed to a complex microbial world within the birth canal and ingestion of this fluid by offspring likely serves as a primary mode of widespread maternal microbial transmission ([@bib63]). Notably, the gastric content and bacterial serotypes isolated from the nasopharynxes of newborns were similar to those of their mothers\' vagina immediately before birth ([@bib12], [@bib16]). Additionally, *Streptococcus* or *Lactobacillus* dominance in the maternal vagina has been associated with a similar predominance pattern in her offspring\'s gut ([@bib64]), and *Lactobacillus* species of maternal origin (e.g., *L. crispatus*, *L. fermentum*, *L. gasseri*, and *L. vaginalis*) have been isolated from infant fecal samples ([@bib68], [@bib19]).

Importantly, a variety of environmental factors may disrupt the vertical transmission of microbiota with potential impacts on early development ([@bib122]). Widespread obstetric practices such as vaginal cleansing with disinfectants and application of antiseptic creams shortly before birth have been shown to reduce maternal transmission of *Streptococcus agalactiae*, a bacteria involved in group B streptococcal (GBS) sepsis in the newborn ([@bib103]). However, the spectrum of activity of these disinfectants includes many beneficial microbes such as *Lactobacillus* and its use has been attributed in preventing colonization of the newborn with commensal bacteria from the maternal vagina ([@bib107]). Moreover, administration of intrapartum antibiotics as a preemptive prophylaxis against GBS infection leads to dysbiosis of the vaginal flora characterized by a shift from a *Lactobacillus-*dominant environment to an antibiotic-resistant polymicrobial mixture such as *Klebsiella, Citrobacter, Enterobacter,* and *Escherichia coli* ([@bib105], [@bib55], [@bib40], [@bib76]). Vertical transmission of these antibiotic-resistant coliforms influences early colonization patterns of the neonate and the effects of maternal antibiotic treatment on offspring gut microbiota persist well after cessation of treatment ([@bib105], [@bib55], [@bib40], [@bib76]). More recent rodent studies have shown that maternal exposure to low dose antibiotics during lactation depleted *Lactobacillus* abundance, increased fat mass, and altered metabolic hormones in offspring ([@bib29], [@bib28]). Further, transfer of these disrupted microbiota to germ-free mice was sufficient to recapitulate the obesity phenotype, supporting that microbiota disruption was sufficient for long-term programing of host metabolic dysfunction ([@bib17]). These results exhibit strong translational value in light of a recent report drawing associations between antibiotic exposure during the first 6 months following birth and an increased body mass ([@bib112]).

Early colonization of a stable core microbiota is also influenced by mode of delivery ([@bib95], [@bib93], [@bib94], [@bib27]). Vaginal bacteria from the mother initially colonize the intestine of vaginally delivered infants, whereas bacteria from the mother\'s skin and the local environment (e.g., healthcare workers, air, other newborns) colonize infants born via caesarean section. Newborns delivered by caesarean section show delayed colonization by *Bacteroides* and *Bifidobacterium*, as well as an overgrowth of *Clostridium difficile*. The resulting differences in colonizing microbiota for vaginally and caesarean delivered children persist well into childhood and are associated with increased body mass and childhood obesity ([@bib95], [@bib13]). Taken together, environmental factors exhibit great influence on vertical transmission of microbiota, early colonization patterns, and long-term programming of metabolic function.

4. Microbe-derived metabolites {#sec4}
==============================

The mutualistic nature of the host-microbe relationship relies on interactions between microbial metabolite production and the host immune, endocrine, and neural systems. Bacterial colonization of the neonatal gut beginning with beneficial pioneer species is critical during the early developmental window, and provides an important source of metabolites for the neonate. The relative composition, diversity and abundance of beneficial bacteria modulates the level of synthesis of a vast array of neuromodulatory molecules and neurotransmitters, including catecholamines, gamma-aminobutyric acid (GABA), serotonin, tryptophan, glutamate, acetylcholine and histamine ([@bib52], [@bib48], [@bib119], [@bib57], [@bib91]). The microbial control of GABA, tryptophan, and serotonin metabolism within the context of neurodevelopmental risk and resilience has been exquisitely reviewed elsewhere ([@bib41], [@bib80]).

Invertebrate model systems, such as *Caenorhabditis elegans* and *Drosophila melanogaster,* have revealed that the activity of the microbiome and its metabolic products directly influence host development and physiology ([@bib18], [@bib90], [@bib98], [@bib102], [@bib97]). More recent advances in rodent models are beginning to elucidate the physiological roles of gut metabolites in mammals. Commensal bacteria in the mammalian gut actively ferment soluble dietary carbohydrates and produce a variety of biologically active metabolites, commonly referred to short chain fatty acids (SCFA\'s), including butyrate, acetate and propionate. Of these metabolites, propionate and butyrate readily cross the gut-blood and blood--brain barriers via a monocarboxylate transporter ([@bib54], [@bib11], [@bib26]). In the brain, propionate and other SCFAs impact neuronal metabolism as well as the synthesis and release of neurotransmitters during early neurodevelopment ([@bib83], [@bib85]). Importantly, a careful balance of brain SCFAs must be achieved, as excessive levels have been associated with neural mitochondrial dysfunction and severe behavioral deficits in rodents ([@bib62], [@bib33], [@bib34], [@bib32]).

In addition to their direct role in fermentation, commensal gut microbiota express many enzymes with immunomodulatory and neuromodoulatory implications. For example, the gene encoding histidine decarboxylase (HDC), which catalyzes the conversion of [l]{.smallcaps}-histidine to histamine, was recently identified in *Lactobacillus reuteri,* a beneficial microbe found in the gut of rodents and humans ([@bib109]). Critically, circulating histidine availability is also directly proportional to histidine content and histamine synthesis in the brain ([@bib96], [@bib108]). Histaminergic fibers originate from the tuberomamillary region of the posterior hypothalamus and project widely to most regions of the developing brain, including the hippocampus, dorsal raphe, cerebellum, and neighboring nuclei of the hypothalamus ([@bib82]). The ability of microbiota to modulate synthesis of a vast array of neuromodulatory molecules highlight the need for additional studies characterizing of the role of microbiota-derived metabolites on broad neurodevelopmental events.

Accumulating evidence draws associations between microbe-generated metabolites during early development and endophenotypes of neuropsychiatric disease. Studies in GF mice revealed that microbial exposure during early life modulated dopamine signaling, neuronal mitochondrial function, neuroplasticity, and motivational behaviors in adult animals ([@bib35], [@bib69]). Further, in a mouse model of maternal immune activation during pregnancy, decreased abundance of the beneficial *Bacteroides fragilis* and increased serum levels of microbe-derived metabolites 4-ethylphenylsulfate and indolepyruvate were observed in exposed offspring. Direct administration of these metabolites to unexposed offspring increased adult anxiety-like behaviors similar to those observed following maternal immune activation, supporting that microbe-generated metabolites may affect brain programming ([@bib50]). The findings are consistent with available epidemiological studies where disruption of microbe-generated metabolites has been reported in children with comorbid presentation of gastrointestinal dysfunction and autism spectrum disorders (ASD) ([@bib118], [@bib66]). Reduced urinary levels of carnosine, glycine, serine, threonine, alanine and histidine have also been observed in children with ASD, suggesting an imbalance of resident gut bacteria involved in both amino acid and carbohydrate metabolism may be present ([@bib120], [@bib73]). A reduced capacity for nutrient digestion and transport in children with ASD has been related to increased levels of *Clostridium* species, *Bacteriodetes* depletion, and loss of metabolites related to energy homeostastis (e.g disaccharidases, hexose transporters) ([@bib120]). Future efforts should focus on putative mechanisms by which microbe-dependent production of neuromodulatory metabolites can result in neurodevelopmental dysregulation predictive of disease.

5. Stress and microbiota {#sec5}
========================

The consequence of environmental stressors on gut microbiome composition in adults has been established for nearly four decades ([@bib106]). This association was first developed from observations that short-term environmental challenges -- deprivation from food, water, and bedding -- decreased the abundance of beneficial bacteria, such as *Lactobacillus*, and increased the susceptibility to opportunistic pathogens in mice ([@bib106]). However, quantification of bacteria in these early studies was limited to phyla that could be cultured in the lab, failing to account for \>99% of microorganisms that could not be cultivated by standard techniques ([@bib51]). Recent advances in metagenomic analyses have identified microbial communities not previously cataloged, and captured a more complete representation of the microbial composition in the intestine ([@bib58], [@bib36], [@bib61], [@bib8]). With these improved technologies, reduced microbial richness and opportunistic overgrowth of bacteria have been subsequently reported in animal models where adult chronic stress was examined, and where long-term programming changes in the HPA stress axis were found ([@bib5]). Additionally, social stress-mediated depletion of *Lactobacillus* was associated with increased translocation of cutaneous-derived microflora to the inguinal and mesenteric lymph nodes ([@bib5], [@bib4], [@bib6]). Although the mechanistic significance of bacteria translocation in these lymphoid organs on HPA axis reprogramming is not clear, sympathetic and noradrenergic innervation of lymphoid organs plays a critical role in the neuroimmune modulation of the HPA axis ([@bib39]).

5.1. Early life stress and neonate gut ecology {#sec5.1}
----------------------------------------------

Stress pathway dysregulation is the most common symptom in neuropsychiatric disorders, yet mechanisms involved in determining potential developmental windows of susceptibility are not fully understood. Animal models of maternal stress have provided insight into the long-term programming of offspring outcomes, but characterization of the role of maternal stress on bacterial colonization patterns and early life programming is only emerging ([@bib79], [@bib2], [@bib3]). Maternal stress during pregnancy has been shown to alter the microbial composition of the offspring gut ([@bib3]). Pregnant rhesus macaques were exposed to acoustic startle stress during a period of either early (days 50--92) or late (days 105--147) gestation and then the offspring gut microbiota characterized postnatally at 2 days and 2, 8, 16, and 24 weeks. Offspring exposed to early gestational stress exhibited *Lactobacillus* depletion, while *Bifidobacteria* and *Lactobacillus* abundance were depleted in offspring exposed to stress during late gestation, suggesting a temporal specificity of stress impact on microbiota. Infants exposed to stress during gestation also exhibited subclinical colonization with the opportunistic pathogen *Shigella flexneri* during the first 24 weeks of life.

Similar to prenatal stress, maternal separation reduced fecal *Lactobacillus* abundance in separated offspring relative to nonseparated cohorts in rhesus macaques (*Macaca mulatta*) ([@bib2]). *Lactobacillus* depletion was associated with increased distress-related behaviors and increased susceptibility to bacterial infection three days post-separation ([@bib2]). Maternal separation also elicited elevated cortisol levels in separated offspring relative to non-separated cohorts, although this increase in stress responsivity was not correlated with *Lactobacillus* levels. More recently, an investigation of maternal separation in a rodent model reported long-term disruption of offspring microbial communities, which may contribute to the increased stress reactivity and anxiety-like behaviors observed in these animals as adults ([@bib79]). Interestingly, concurrent treatment with *Lactobacillus* probiotics during the early phase of maternal separation mitigated maternal separation-mediated corticosterone release in pups, a direct measure of HPA axis responsivity ([@bib43]), illustrating the potential therapeutic benefit of microbial populations. Potential mechanisms by which stress-mediated changes in early gut microflora may affect brain development are discussed below.

5.2. Microbial programming of the brain {#sec5.2}
---------------------------------------

The role of the early gut microbiota in neurodevelopmental programming and stress-related risk and resilience has been largely established through the use of germ-free (GF) mice that are born and raised under axenic conditions, devoid of all microorganisms. For example, exposure of GF male and female mice to restraint stress was associated with aberrant ACTH and corticosterone profiles, downregulation of brain derived neurotrophic factor (BDNF) expression in the hippocampus and glucocorticoid receptor and *N*-methyl-d-aspartate receptor subunit 2a (NR2a) expression in the cortex ([@bib104], [@bib24]). However, similar changes were not observed following restraint of conventionally housed mice suggesting that the absence of the early microbiota influences stress responsivity into adulthood. Further, monoassociation with *Bifidobacterium infantis*, a bacterium commonly isolated from the neonate gut, partially rescued the HPA stress activation, and gnotobiotic mice reconstituted with normal specific pathogen-free microbiota exhibited decreased anxiety-like behaviors ([@bib104], [@bib24], [@bib78]).

Further evidence of the role of microbiota in shaping stress pathway regulation comes from the study of serotonergic dysregulation, a common feature in sex-specific affective disorders ([@bib89], [@bib44]). Consistent with previous reports of sex differences in serotonergic neurocircuitry and established sex differences in the HPA axis stress response ([@bib44]), hippocampal serotonin and 5-HIAA, the main metabolite of serotonin, concentrations were higher in conventionally colonized (CC) female mice than in males ([@bib24]). Interestingly, serotonin and 5-HIAA levels remain unchanged in GF females relative to CC females, while concentrations of these monoamines and metabolites were increased to female-typical levels in GF male mice ([@bib24]), suggesting potential dysmasculinization of hippocampal serotonergic neurocircuitry in GF males. Consistent with previous work on early life stress and sex-specific dysregulation of neuroplasticity ([@bib75]), BDNF expression was decreased in the hippocampus of GF male, but not GF female mice ([@bib24]). While bacterial colonization of GF males during the post-weaning period did not rescue hippocampal serotonergic alterations, this treatment successfully rescued altered anxiety-like behaviors observed in male GF mice ([@bib24]). This demonstration of the absence of a normal gut microbiota exhibiting consequences on neurodevelopment and adult behavior in males but not females introduces the possibility that the microbiome may also contribute to a larger extent to sex differences in the susceptibility to disease.

Of great importance to stress pathway regulation, a direct interaction between gonadal hormones and microbial exposure in mediating sex-specific disease risk has been recently illustrated ([@bib65], [@bib123]). The incidence of autoimmune disorders such as type 1 diabetes (T1D) displays a strong female bias, with nearly twice as many females affected as males ([@bib84]). Similar sex-specific susceptibility is observed in the non-obese diabetes (NOD) mouse model where female NOD mice exhibit increased incidence of T1D pathogenesis relative to NOD males ([@bib84]). To examine if phenotypes are related to the sex-specific microbiome profiles observed in NOD mice, which emerge at the onset of puberty and remain stable well into adulthood, researchers transferred male cecal contents into pubertal NOD female mice. Remarkably, this transfer resulted in masculinization of the microbial composition, increased testosterone levels, and metabolite profile of glycerophospholipids and sphingolipids in female recipients, demonstrating, amazingly, that male microbiota provides sex-specific protective effects against T1D pathogenesis ([@bib65]). Notably, commensal bacteria may be directly responsible for testosterone production and its effects on metabolism, as both male and female NOD mice exhibited altered testosterone profiles and T1D-like pathology when reared under germ-free conditions. These studies are among the first to demonstrate the ability of microbial transfer to impact disease risk and resilience. Behavioral phenotypes also appear to be transmissible via the microbiota, as germ-free NIH Swiss mice inoculated with cecal contents from BALB/c mice, an innately anxious strain of mice, displays a behavioral phenotype similar to the donor species ([@bib10]). These combined results have important implications for the etiology and potential treatment of functional gastrointestinal intestinal disorders, which are female biased in presentation and comorbid with psychiatric disorders, including anxiety and depression ([@bib20], [@bib72], [@bib81]). Thus, microbiota transfer studies across a variety of experimental conditions will undoubtedly expand our understanding of the role of the microbiota in biological processes, including brain development, immunity, and metabolic function.

6. Conclusions and future directions {#sec6}
====================================

The quality of the early postnatal environment influences the course of development, which in turn determines the health of the individual across the life span. Transmission of individual differences in behavioral and physiological responses to environmental stimuli is a key factor in predicting stress-related disorders. To date, alterations in maternal care, diet, and stress are known influences on sex-specific outcomes related to offspring disease vulnerability ([@bib7]). Vertical transmission of maternal microbes to offspring is emerging as a factor in transgenerational disease risk and resilience. The vaginal microbiome influences early-host microbe interactions in the neonate, and therefore affects long-term programming of microbial colonization patterns, immune function, metabolic status, neurodevelopment, and disease risk into adulthood. From a clinical perspective, screening of the vaginal flora during late pregnancy may also provide critical insight into the early colonization patterns of the newborn gastrointestinal tract and associated disease risk.

The mechanisms underlying the communication between the developing central nervous system and gastrointestinal tract likely involve microbial production of neuromodulatory metabolites, vagal nerve innervation, and innate immunity. Emerging reports suggest that microbe derived metabolites can be both beneficial and detrimental to host development, although more research is needed to identify and characterize the downstream targets of these metabolites ([@bib50], [@bib37]). Finally, vaginal microbial communities are plastic, and can be rapidly altered following dietary, probiotic, and environmental interventions. This gives rise to the intriguing possibility that therapeutic treatment of vaginal microbiota may be a viable target for maternal stress and immune related neurodevelopmental disorder prevention.
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![A proposed model for the role of maternal microbial transmission in early life programming and neurodevelopment. Environmental perturbations, such as stress or infection, during pregnancy destabilize the vaginal ecosystem that may lead to dysbiosis of the vaginal flora characterized by a shift from a *Lactobacillus*-dominant (symbionts) environment to overgrowth of opportunistic pathogens (pathobionts). Vertical transmission of a disrupted microbiota may compromise key developmental processes of the neonate, including the synthesis and absorption of microbe-derived metabolites, maturation of the gastrointestinal tract, and immune function. Outcompetition by pathobionts in the neonatal gut may increase production of detrimental metabolites and alter downstream neurodevelopmental events, including development of the hypothalamic-pituitary-adrenal (HPA) stress axis, as its development overlaps with early colonization patterns of the neonatal gut. Disruption during this critical window may result in long-term programming that persists even after stable core microbiota has been established. Administration of probiotics or dietary factors that promote maturation of the neonatal gut provide a promising avenue of therapeutic treatments by which to modulate microbiota composition, metabolic function, and neurodevelopment of the host.](gr1){#fig1}
